[Inhibition of Chlamydia trachomatis multiplication by interferon inducer larifan in mice with experimental infection]. 1990

N A Vinograd, and A M Saĭitkulov, and E B Tazulakhova, and F I Ersnov

Interferon (IF)-inducing capacity of C. trachomatis was shown in experiments on mice CBA. The levels of IF production in the parenchymatous organs correlated with accumulation of the pathogen in them. The use of larifan, a natural double-stranded IF inductor, according to the treatment scheme provided high levels of endogenic IF in infected mice. It inhibited multiplication of Chlamydiae in the lungs and lymph nodes detected cytoscopically by light and fluorescence microscopy and with infection titration. The effect of the inductor combined with tetracycline was of additive nature. Double intraperitoneal administration of larifan with an account of the hyporeactivity phase and daily administration of tetracycline proved to be the most efficient. It is possible to successfully use IF inductors in accordance with the treatment schemes in infection caused by C. trachomatis which makes promising their clinical application in therapy of chlamydiosis.

UI MeSH Term Description Entries
D007369 Interferon Inducers Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. Inducers, Interferon
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D009930 Organic Chemicals A broad class of substances containing carbon and its derivatives. Many of these chemicals will frequently contain hydrogen with or without oxygen, nitrogen, sulfur, phosphorus, and other elements. They exist in either carbon chain or carbon ring form. Organic Chemical,Chemical, Organic,Chemicals, Organic
D002690 Chlamydia Infections Infections with bacteria of the genus CHLAMYDIA. Infections, Chlamydia,Chlamydia Infection,Infection, Chlamydia
D002692 Chlamydia trachomatis Type species of CHLAMYDIA causing a variety of ocular and urogenital diseases.
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013752 Tetracycline A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis. 4-Epitetracycline,Achromycin,Achromycin V,Hostacyclin,Sustamycin,Tetrabid,Tetracycline Hydrochloride,Tetracycline Monohydrochloride,Topicycline,4 Epitetracycline

Related Publications

N A Vinograd, and A M Saĭitkulov, and E B Tazulakhova, and F I Ersnov
January 1991, Voprosy virusologii,
N A Vinograd, and A M Saĭitkulov, and E B Tazulakhova, and F I Ersnov
May 1985, Infection and immunity,
N A Vinograd, and A M Saĭitkulov, and E B Tazulakhova, and F I Ersnov
March 1997, Biochemical and biophysical research communications,
N A Vinograd, and A M Saĭitkulov, and E B Tazulakhova, and F I Ersnov
July 2017, Infection and immunity,
N A Vinograd, and A M Saĭitkulov, and E B Tazulakhova, and F I Ersnov
May 2002, Infection and immunity,
N A Vinograd, and A M Saĭitkulov, and E B Tazulakhova, and F I Ersnov
July 2003, The Journal of infection,
N A Vinograd, and A M Saĭitkulov, and E B Tazulakhova, and F I Ersnov
February 1983, Infection and immunity,
N A Vinograd, and A M Saĭitkulov, and E B Tazulakhova, and F I Ersnov
August 1993, Infection and immunity,
N A Vinograd, and A M Saĭitkulov, and E B Tazulakhova, and F I Ersnov
June 1997, Infection and immunity,
N A Vinograd, and A M Saĭitkulov, and E B Tazulakhova, and F I Ersnov
December 2023, Microbial pathogenesis,
Copied contents to your clipboard!